195 related articles for article (PubMed ID: 35124288)
1. Induction and Regulation of the Innate Immune Response in Helicobacter pylori Infection.
Gobert AP; Wilson KT
Cell Mol Gastroenterol Hepatol; 2022; 13(5):1347-1363. PubMed ID: 35124288
[TBL] [Abstract][Full Text] [Related]
2. Review article: exploring the link between Helicobacter pylori and gastric cancer.
Kuipers EJ
Aliment Pharmacol Ther; 1999 Mar; 13 Suppl 1():3-11. PubMed ID: 10209681
[TBL] [Abstract][Full Text] [Related]
3. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
4. The interleukin-8-251 A allele is associated with increased risk of noncardia gastric adenocarcinoma in Helicobacter pylori-infected Koreans.
Ye BD; Kim SG; Park JH; Kim JS; Jung HC; Song IS
J Clin Gastroenterol; 2009 Mar; 43(3):233-9. PubMed ID: 18542040
[TBL] [Abstract][Full Text] [Related]
5. Gastric mucosal precancerous lesions in
Yu M; Ma J; Song XX; Shao QQ; Yu XC; Khan MN; Qi YB; Hu RB; Wei PR; Xiao W; Jia BL; Cheng YB; Kong LF; Chen CL; Ding SZ
World J Gastroenterol; 2022 Jul; 28(28):3682-3694. PubMed ID: 36161049
[TBL] [Abstract][Full Text] [Related]
6. Role of Helicobacter pylori in gastric carcinoma.
Prabhu SR; Amrapurkar AD; Amrapurkar DN
Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060
[TBL] [Abstract][Full Text] [Related]
7. PBX1 attributes as a determinant of connexin 32 downregulation in
Liu XM; Xu CX; Zhang LF; Huang LH; Hu TZ; Li R; Xia XJ; Xu LY; Luo L; Jiang XX; Li M
World J Gastroenterol; 2017 Aug; 23(29):5345-5355. PubMed ID: 28839434
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
[TBL] [Abstract][Full Text] [Related]
9. High expression of Helicobacter pylori VapD in both the intracellular environment and biopsies from gastric patients with severity.
Morales-Espinosa R; Delgado G; Serrano LR; Castillo E; Santiago CA; Hernández-Castro R; Gonzalez-Pedraza A; Mendez JL; Mundo-Gallardo LF; Manzo-Merino J; Ayala S; Cravioto A
PLoS One; 2020; 15(3):e0230220. PubMed ID: 32163505
[TBL] [Abstract][Full Text] [Related]
10.
Lim NR; Chung WC
Korean J Gastroenterol; 2023 Oct; 82(4):171-179. PubMed ID: 37876256
[TBL] [Abstract][Full Text] [Related]
11. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection and expression of the angiogenic factor platelet-derived endothelial cell growth factor by pre-neoplastic gastric mucosal lesions and gastric carcinoma.
Franceschi F; Genta RM; Gasbarrini A; Gentiloni Silveri N; Gasbarrini G; Sepulveda AR
Dig Liver Dis; 2002 Sep; 34(9):621-5. PubMed ID: 12405247
[TBL] [Abstract][Full Text] [Related]
13. GATA-3 augmentation down-regulates Connexin43 in Helicobacter pylori associated gastric carcinogenesis.
Liu X; Cao K; Xu C; Hu T; Zhou L; Cao D; Xiao J; Luo L; Guo Y; Qi Y
Cancer Biol Ther; 2015; 16(6):987-96. PubMed ID: 25901741
[TBL] [Abstract][Full Text] [Related]
14. Expression of TFF2 and Helicobacter pylori infection in carcinogenesis of gastric mucosa.
Hu GY; Yu BP; Dong WG; Li MQ; Yu JP; Luo HS; Rang ZX
World J Gastroenterol; 2003 May; 9(5):910-4. PubMed ID: 12717829
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
16. Trends over time in Helicobacter pylori gastritis in Kenya.
McFarlane GA; Wyatt J; Forman D; Lachlan GW
Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):617-21. PubMed ID: 10912478
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer.
Farinati F; Valiante F; Germanà B; Della Libera G; Baffa R; Rugge M; Plebani M; Vianello F; Di Mario F; Naccarato R
Eur J Cancer Prev; 1993 Jul; 2(4):321-6. PubMed ID: 8358284
[TBL] [Abstract][Full Text] [Related]
18. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
19. Atrophic gastritis in Helicobacter pylori-infected children.
Hsieh H; Yang HB; Sheu BS; Yang YJ
Helicobacter; 2022 Jun; 27(3):e12885. PubMed ID: 35306717
[TBL] [Abstract][Full Text] [Related]
20. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
Kapadia CR
J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
